Dahlman Rose Reiterates a 'Buy' on Molycorp (MCP); Share Registration Does Not Change the Fundamentals
Tweet
Share
E-mailGet Alerts MCP Hot Sheet
Price: $0.36 --0%
Rating Summary:
2 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Dahlman Rose reiterates a 'Buy' on Molycorp (NYSE: MCP), PT $125.
Dahlman analyst said, "The possible sale by insiders could create a near-term overhang as the market digests the additional inventory, but we note that any valuation analysis should already have accounted for these shares. Over the medium to long term, it is possible that the additional float may help to mute some of the volatility in MCP shares, making an investment in the shares more attractive to investors who cannot tolerate the current volatility."
For more ratings news on Molycorp click here and for the rating history of Molycorp click here.
Shares of Molycorp closed at $59.03 yesterday.
Dahlman analyst said, "The possible sale by insiders could create a near-term overhang as the market digests the additional inventory, but we note that any valuation analysis should already have accounted for these shares. Over the medium to long term, it is possible that the additional float may help to mute some of the volatility in MCP shares, making an investment in the shares more attractive to investors who cannot tolerate the current volatility."
For more ratings news on Molycorp click here and for the rating history of Molycorp click here.
Shares of Molycorp closed at $59.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- McGraw Hill (MH) PT Raised to $15 at UBS
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
